Triple
T2190754
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Janssen COVID-19 Vaccine |
E49854
|
entity |
| Predicate | targetVirus |
P34395
|
FINISHED |
| Object | SARS-CoV-2 |
E123479
|
NE FINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: SARS-CoV-2 | Statement: [Janssen COVID-19 Vaccine, targetVirus, SARS-CoV-2]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: SARS-CoV-2 Context triple: [Janssen COVID-19 Vaccine, targetVirus, SARS-CoV-2]
-
A.
Omicron
Omicron is a vowel letter of the Greek alphabet, historically representing a short "o" sound and used today in various scientific and mathematical contexts.
-
B.
COVID-19 pandemic
The COVID-19 pandemic is a global outbreak of the coronavirus SARS-CoV-2 that began in late 2019, causing widespread illness, deaths, and major disruptions to societies and economies worldwide.
-
C.
RSV
RSV is a widely used mid-20th-century English translation of the Bible that sought to update archaic language while retaining a traditional literary style.
-
D.
Leqembi
Leqembi is an Alzheimer’s disease drug (lecanemab) that targets amyloid-beta plaques to slow cognitive decline in early-stage patients.
-
E.
COVID-19 vaccines
chosen
COVID-19 vaccines are immunizations developed to protect against the SARS-CoV-2 virus, significantly reducing the risk of severe illness, hospitalization, and death from COVID-19.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: targetVirus Context triple: [Janssen COVID-19 Vaccine, targetVirus, SARS-CoV-2]
-
A.
target
Indicates that one entity is the intended object, goal, or focus of another entity’s action or attention.
-
B.
virusSubtype
Indicates the specific subtype classification of a virus within a broader virus type or strain.
-
C.
targetVertical
Indicates that one entity is directed toward, aligned with, or intended for a specific vertical market, domain, or industry segment.
-
D.
victoryTarget
Indicates that one entity is the intended opponent, objective, or condition that must be overcome or achieved for the other entity to attain victory.
-
E.
targetOfIntervention
chosen
Indicates that an entity is the object or focus upon which an intervention, treatment, or action is directed.
- F. None of above.
Provenance (4 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69a88aaba3c48190b351cab9b26989ff |
completed | March 4, 2026, 7:40 p.m. |
| NER | Named-entity recognition | batch_69abbf9e99f08190892d34485c8f2f25 |
completed | March 7, 2026, 6:03 a.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69ae5db0352c8190aa9c4c58460df3a4 |
completed | March 9, 2026, 5:42 a.m. |
| PD | Predicate disambiguation | batch_69abbda32d1881909d1fd83a751fb21c |
completed | March 7, 2026, 5:54 a.m. |
Created at: March 4, 2026, 7:46 p.m.